Kimbria Blake

Kimbria Blake has a strong background in scientific research, with experience in both academia and industry. Kimbria has worked as a Senior Study Director at GENOSKIN since 2023, where they are involved in overseeing and managing research studies. Prior to this role, they served as a Scientist/Study Director at the same company from 2021 to 2023.

Before joining GENOSKIN, Kimbria worked as a Postdoctoral Researcher at Harvard University from 2020 to 2021. During this time, they focused on studying the mechanisms of itch in a mouse epicutaneous Staphylococcus aureus skin infection model that mimics the characteristics of atopic dermatitis (AD), a chronic inflammatory allergic skin condition. Their research aimed to better understand the role of S. aureus in AD and contribute to the development of effective treatments.

Overall, Kimbria brings extensive scientific expertise and a clear focus in dermatology research to their current role at GENOSKIN.

Kimbria Blake pursued their education between the years 2010 and 2014 at Rochester Institute of Technology, where they earned their Bachelor of Science degree in Biochemistry. Subsequently, from 2014 to 2020, they attended Harvard University, where they obtained a Doctor of Philosophy (PhD) degree in Biological and Biomedical Sciences.